Clinical Applications and Prevention
Behavioral, environmental, clinical, and healthcare approaches to reduce the occurrence and consequences of cardiovascular diseases. Studies include clinical and community trials and selected observational studies.
Program Officers
Rebecca Campo, Ph.D.
Social determinants of health, psychosocial risk
301-594-1047
Laurie Friedman Donze, Ph.D.
Obesity; physical activity; psychiatric comorbidities of CVD; adherence
301-827-1408
Lawrence Fine, M.D., Dr.PH, FAHA
Senior Advisor; Hypertension; prevention
301-435-0305
Charlotte Pratt, Ph.D., M.S., R.D, FAHA
Deputy Branch Chief; Nutrition; CVH across the Lifespan
301-435-0382
Nicole Redmond, M.D., Ph.D., M.P.H.
Branch Chief; Health equity; career development
301-435-0379
Eric Shiroma, Sc.D., MEd, FACSM
Physical activity; Life course epi; Big Data Methods
301-480-2695
Gladys Tataw-Ayuketah, Ph.D., M.P.H., R.N.
Clinical Trials Specialist
301-435-0702